Heart failure development program to focus on Short Term DSR with DSR 2.0
July 20, 2022
Sequana Medical Completes Enrollment in Phase 2a SAHARA I DSR Study
July 20, 2022 — Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease and…
Read More
CardioFocus is leveraging the outstanding clinical performance of its flagship HeartLight X3 System to address the shortcomings of the currently available catheters being used to deliver PFA for pulmonary vein isolation (PVI).
July 20, 2022
CardioFocus Announces Pulsed Field Ablation Milestones
July 20, 2022 — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial…
Read More
2.3 million cardiomyopathy cases expected in the US by 2031, representing 83% of total cases in the 7MM
July 19, 2022
US to See a Staggering Number of Cardiomyopathy Cases by 2031, Says GlobalData 
July 19, 2022 — Research by GlobalData has highlighted the startling difference between the forecast number of…
Read More
On July 7, the Centers for Medicare & Medicaid Services (CMS) released the 2023 Medicare Physician Fee Schedule (PFS) proposed rule
July 19, 2022
CMS Releases 2023 Medicare Physician Fee Schedule Proposed Rule
July 19, 2022 — On July 7, the Centers for Medicare & Medicaid Services (CMS) released the 2023 Medicare Physician…
Read More
The Cardiovascular AI Initiative, to be funded by NewYork-Presbyterian, was launched this summer in a virtual meeting featuring approximately 40 representatives from the institutions.
July 19, 2022
Collaboration Will Advance Cardiac Health Through AI
July 19, 2022 — Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is…
Read More
3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging Excellence Advisory Services to support radiology departments in hospital and outpatient settings nationwide
July 19, 2022
3DR Labs Introduces New Imaging Services to Meet Specific Radiology Market Needs
July 18, 2022 — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and…
Read More
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark submission for its MAGiC catheter.
July 19, 2022
Stereotaxis Announces CE Mark Submission for Robotically Navigated Magic Ablation Catheter
July 18, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular…
Read More
July 19, 2022
scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure
July 18, 2022 —  scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products…
Read More
July 18, 2022
SCCT2022 Presents Distinguished Awards
During the Society of Cardiovascular Computed Tomography 17th Annual Scientific Meeting (SCCT2022), three awards were…
Read More
The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer
July 15, 2022
ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer
July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer…
Read More
MMRI Scientist Dr. Nathan Tucker co-authors groundbreaking study with team from The Broad Institute of MIT and Harvard, Bayer AG
July 15, 2022
Molecular Heart Mapping and Cripsr Technology Create New Possibilities for Health Science
July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled…
Read More
The American Heart Association, the leading voluntary organization devoted to longer, healthier lives, recognizes structural racism as a major cause of poor health and premature death from heart disease and stroke
July 15, 2022
Winning Scientific Research Announced for Heart Failure and Social/Structural Determinants of Health
July 15, 2022 — The American Heart Association, the leading voluntary organization devoted to longer, healthier lives,…
Read More
This model heart ventricle, made with real living heart cells, beats strongly enough to pump fluid inside a tube. It can be used to study heart disease and test out potential therapies, without the need for invasive surgery.
July 14, 2022
Reverse Engineering the Heart: University of Toronto Engineering Team Creates Bioartificial Left Ventricle 
July 14, 2022 — University of Toronto Engineering researchers have grown a small-scale model of a human left heart…
Read More
More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health, especially among people of color, putting both parents-to-be and their babies at risk, according to the American Heart Association Heart Disease and Stroke Statistics 2022 Update.
July 14, 2022
$20 Million Awarded for Research to Improve Outcomes in Pregnancy, Infant CVD Health 
July 14, 2022 — More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health,…
Read More
Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of artificial intelligence (AI)-powered software solutions that will detect hidden cardiovascular conditions
July 14, 2022
Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence
July 14, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a…
Read More
July 14, 2022
AvoMD Partners with the SCCT to bring guidelines to the point-of-care
July 14, 2022 – AvoMD, a next-generation application-based clinical decision support platform, is working with the…
Read More
The authors analyzed data about 8,224 children who received cardiac transplants from January 1994 through September 2019. The data came from the Scientific Registry of Transplant Recipients (SRTR), a national database of all organ transplants in the United States. The researchers adjusted their analyses for factors including age, sex, cognitive difficulties, insurance status, transplant year and the reason for heart transplant.
July 13, 2022
Study Finds Risk Disparity for Black Children Who Have Stroke After Heart Transplant
July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as…
Read More
Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD),
July 13, 2022
Johns Hopkins Medicine Study: Abnormal Heart Metabolism May Predict Future Sudden Cardiac Death 
July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening…
Read More
the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch Ventricular Restoration System
July 13, 2022
Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System
July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today…
Read More
July/August 2022 issue of Diagnostic and Interventional Cardiology
July 13, 2022
DAIC's July/August Digital Edition is Now Available
View the July/August digital edition of Diagnostic and Interventional Cardiology (DAIC), including links to videos,…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now